1251 Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mice model of rhododendrol-induced leukoderma

Authors :: Tamio Suzuki
Masahiro Hayashi
Y. Hozumi
K. Okamura
I. Saito
Yuko Abe
Source :: Journal of Investigative Dermatology. 138:S212
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Tofacitinib
business.industry
Leukoderma
Cell Biology
Dermatology
Pharmacology
medicine.disease
Biochemistry
030207 dermatology & venereal diseases
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Rhododendrol
medicine
business
Molecular Biology
Janus kinase inhibitor

Tools